Upadacitinib 15 MG [Rinvoq]

DRUG3 trials

Sponsors

CARE ARTHRITIS LTD., I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Conditions

Axial Spondylarthritis (axSpA)Psoriatic ArthritisPsoriatic Arthritis (PsARheumatoid Arthritis (RASpondyloarthritis, Axial

Phase 4

A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis

RecruitingNCT06454188

CARE ARTHRITIS LTD.Psoriatic Arthritis, Spondyloarthritis, Axial

Start: 2024-12-03End: 2028-10-01Target: 100Updated: 2026-04-03

Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis

Not yet recruitingNCT07018206

CARE ARTHRITIS LTD.Axial Spondylarthritis (axSpA)

Start: 2026-05-01End: 2027-05-01Target: 200Updated: 2026-02-06

Unknown Phase

Efficacy Of Upadacitinib In Psoriatic Arthritis And Comparison To Rheumatoid Arthritis.

RecruitingNCT06630715

I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioPsoriatic Arthritis (PsA, Rheumatoid Arthritis (RA

Start: 2024-07-23End: 2025-12-31Target: 178Updated: 2024-10-08